FDA Approves Bristol Myers’ Non-Small Cell Lung Cancer Drug
Augtyro was approved for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer.
Augtyro was approved for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer.
LUNGevity Foundation has launched an Early Lung Cancer Center to accelerate the development and broad adoption of early detection and treatment options.
Known as ‘Sybil,’ the AI tool accurately predicted the risk of lung cancer for individuals with or without a significant smoking history.
AstraZeneca said on Friday its lung cancer drugs Imfinzi and Imjudo have been approved by the U.S. Food and Drug Administration (FDA).
Read MoreSome cancer cells can deploy parallel mechanisms to evade the immune system’s defenses as well as resist immunotherapy treatment, according to a new study from the Garvan Institute of Medical Research.
Read MoreBiodesix offers healthcare providers and patients a comprehensive suite of diagnostic tests capable of supporting clinical decision-making across the lung cancer continuum.
Read MoreAdvisers to the FDA on Thursday voted against recommending Spectrum Pharmaceuticals’ experimental drug for the treatment of patients with a form of non-small cell lung cancer.
Read MoreA recent study in Supportive Care in Cancer examined the findings of a cancer patient experience survey to identify possible patterns in patient-reported experiences of their lung cancer care.
Read MoreAmgen’s Lumakras pill reduced the risk of disease progression in patients with advanced lung cancer by 34% compared with chemotherapy in a clinical trial, the company said on Sunday.
Read MoreThe National Cancer Institute awarded $23M to establish telehealth centers of excellence on the role of telehealth in cancer-related care.
Read MoreSexual dysfunction is a common side effect among women with lung cancer, a new study finds.
Read MoreEach year on August 1st, the global respiratory community recognizes World Lung Cancer Day as a way to increase awareness and resources to fight the disease that accounts for 1-in-4 cancer deaths.
Read MoreA lack of mask mandates at cancer centers has left patients feeling unsafe, according to reports from clinicians.
Read MoreRoche and EarlySign have expanded their partnership to include AI-powered lung cancer diagnosis.
Read MoreThere is a strong relationship between prolonged, low-level radon exposure and lung cancer, indicating a need for enhanced protection measures, according to a study led by the University of California, Irvine.
Read More